Immediate Impact
1 by Nobel laureates 64 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
Works of Peter Cooke being referenced
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
2020
BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder.
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Cooke | 387 | 79 | 57 | 92 | 22 | 491 | |
| Kan Sasaki | 236 | 24 | 12 | 112 | 25 | 475 | |
| Lewis S. Hanna | 139 | 44 | 69 | 33 | 17 | 476 | |
| T.S. O'Brien | 216 | 86 | 21 | 135 | 22 | 536 | |
| H Kaneko | 171 | 174 | 50 | 59 | 25 | 541 | |
| Masahisa Nakagawa | 148 | 155 | 48 | 63 | 24 | 539 | |
| Robert B. Duthie | 206 | 33 | 13 | 60 | 27 | 484 | |
| Martin Röpke | 355 | 25 | 9 | 246 | 26 | 548 | |
| Sophie Morisset | 212 | 35 | 77 | 72 | 16 | 519 | |
| Yongcheng Hu | 272 | 22 | 16 | 124 | 28 | 429 | |
| Yi Zhao | 80 | 48 | 32 | 58 | 28 | 471 |
All Works
Loading papers...